Genetic Risk Factors in Young Patients With Ischemic Colitis

Clinical Gastroenterology and Hepatology

Volumn 6, Issue 8, 2008, Pages 907-911

  Theodoropoulou, Angeliki ^a   Sfiridaki, Aekaterini ^a   Oustamanolakis, Pantelis ^a   Vardas, Emanouel ^a   Livadiotaki, Aekaterini ^a   Boumpaki, Aekaterini ^a   Paspatis, Gregorios ^a   Koutroubakis, Ioannis E ^b  

^a Venizelion General Hospital   (Greece)

^b UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN E; BLOOD CLOTTING FACTOR 5; PLASMINOGEN ACTIVATOR INHIBITOR;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; ISCHEMIC COLITIS; MALE; MORBIDITY; PATHOGENESIS; PREVALENCE; RISK FACTOR;

ADULT; CASE-CONTROL STUDIES; COLITIS, ISCHEMIC; FACTOR V; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HEMOSTASIS; HUMANS; MALE; MIDDLE AGED; PLASMINOGEN INACTIVATORS; POLYMORPHISM, GENETIC; VASOCONSTRICTION;

EID: 47949128966     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2008.03.010     Document Type: Article

References (33)

1. Gandhi S.K., Hanson M.M., Vernava A.M., et al. Ischemic colitis. Dis Colon Rectum 39 (1996) 88
2. Collet T., Even C., Bouin M., et al. Prevalence of electrocardiographic and echocardiographic abnormalities in ambulatory ischemic colitis. Dig Dis Sci 45 (2000) 23-25
3. Blanc P., Bories P., Donadio D., et al. Ischemic colitis and recurrent venous thrombosis caused by familial protein S deficiency. Gastroenterol Clin Biol 13 (1989) 945
4. Yang R.D., Han M.W., and McCathy J.H. Ischemic colitis in a crack abuser. Dig Dis Sci 36 (1991) 238
5. Boutros H.H., Pautler S., and Chakrabarti S. Cocaine-induced ischemic colitis with small vessel thrombosis of colon and gallbladder. J Clin Gastroenterol 24 (1997) 49-53
6. Dowd J., Bailey D., Moussa K., et al. Ischemic colitis associated with pseudoephedrine: four cases. Am J Gastroenterol 94 (1999) 2430-2434
7. Mann Jr. D.E., Kessel E.R., Mullins D.L., et al. Ischemic colitis and acquired resistance to activated protein C in a woman using oral contraceptives. Am J Gastroenterol 93 (1998) 1960-1962
8. Cappell M.S., Mahajan D., and Kurupath V. Characterization of ischemic colitis associated with myocardial infarction: an analysis of 23 patients. Am J Med 119 (2006) 527-529
9. Arnott I.D., Ghosh S., and Ferguson A. The spectrum of ischaemic colitis. Eur J Gastroenterol Hepatol 11 (1999) 295-303
10. Deana D.G., and Dean P.J. Reversible ischemic colitis in young women: association with oral contraceptive use. Am J Surg Pathol 19 (1995) 454-462
11. Brandt L.J., and Boley S.J. AGA technical review on intestinal ischemia. Gastroenterology 118 (2000) 954-968
12. Verger P., Blanc C., Feydy P., et al. Ischemic colitis caused by protein S deficiency. Presse Med 25 (1996) 1350
13. Knot E.A., ten Cate J.W., Bruin T., et al. Antithrombin III metabolism in two colitis patients with acquired antithrombin III deficiency. Gastroenterology 89 (1985) 421-425
14. Ludwig D., Stahl M., David-Walek T., et al. Ischemic colitis, pulmonary embolism, and right atrial thrombosis in a patient with inherted resistance to activated protein C. Dig Dis Sci 43 (1998) 1362-1367
15. Yee N.S., Guerry IV D., and Lichtenstein G.R. Ischemic colitis associated with factor V Leiden mutation. Ann Intern Med 132 (2000) 595-596
16. Barlian A., Veyradier A., Naveau S., et al. Prothrombin 20210G/A mutation in two patients with mesenteric ischemia. Dig Dis Sci 44 (1999) 1910-1913
17. Cervera R., Espinosa G., Cordero A., et al. Intestinal involvement secondary to the antiphospholipid syndrome (APS): clinical and immunologic characteristics of 97 patients: comparison of classic and catastrophic APS. Semin Arthritis Rheum 36 (2007) 287-296
18. Koutroubakis I.E., Theodoropoulou A., Sfiridaki A., et al. Low plasma protein Z levels in patients with ischemic colitis. Dig Dis Sci 48 (2003) 1673-1676
19. Koutroubakis I.E., Sfiridaki A., Theodoropoulou A., et al. Role of acquired and hereditary thrombotic risk factors in colon ischemia of ambulatory patients. Gastroenterology 121 (2001) 561-565
20. Midian-Singh R., Polen A., Durishin C., et al. Ischemic colitis revisited: a prospective study identifying hypercoagulability as a risk factor. South Med J 97 (2004) 120-123
21. Crawford D.C., Akey D.T., and Nickerson D.A. The patterns of natural variation in human genes. Annu Rev Genomics Hum Genet 6 (2005) 287-312
22. Cambien F., and Tiret L. Atherosclerosis: from genetic polymorphisms to system genetics. Cardiovasc Toxicol 5 (2005) 143-152
23. Koutroubakis I.E., Sfiridaki A., Tsiolakidou G., et al. Genetic risk factors in patients with inflammatory bowel disease and vascular complications: case-control study. Inflam Bowel Dis 13 (2007) 410-415
24. Brandt L.J., and Boley S.J. Colonic ischemia. Surg Clin North Am 72 (1992) 203-229
25. Rosendaal F.R. Venous thrombosis: a multicausal disease. Lancet 353 (1999) 1167-1173
26. Caprini J.A., Glase C.J., Anderson C.B., et al. Laboratory markers in the diagnosis of venous thromboembolism. Circulation 109 (2004) I4-I8
27. Lambropoulos A.F., Foka Z., Makris M., et al. Factor V Leiden in Greek thrombophilic patients: relationship with activated protein C resistance test and levels of thrombin-antithrombin complex and prothrombin fragment 1 + 2. Blood Coagul Fibrinolysis 8 (1997) 485-489
28. Koutroubakis I.E., Sfiridaki A., Mouzas I.A., et al. Resistance to activated protein C and low levels of free protein S in Greek patients with inflammatory bowel disease. Am J Gastroenterol 95 (2000) 190-194
29. Paspatis G.A., Sfyridaki A., Papanikolaou N., et al. Resistance to activated protein C, factor V Leiden and the prothrombin G20210A variant in patients with colorectal cancer. Pathophysiol Haemost Thromb 32 (2002) 2-7
30. Dawson S., Hamsten A., Wiman B., et al. Genetic variation as the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity. Arterioscler Thromb 11 (1991) 183-190
31. Eriksson P., Kallin B., Vant Hooft F.M., et al. Allele-specific increase in basal transcription of the plasminogen activator inhibitor-1 gene is associated with myocardial infarction. Proc Natl Acad Sci U S A 92 (1995) 1851-1855
32. Tassies D., Espinosa G., Munoz-Rodriguez F.J., et al. The 4G/5G polymorphism of the 1 plasminogen activator inhibitor gene and thrombosis in patients with antiphospholipid syndrome. Arthritis Rheum 43 (2000) 2349-2358
33. Stegnar M., Uhrin P., Peternel P., et al. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venus thromboembolism. Thromb Haemost 79 (1998) 975-979